Postoperative pulmonary function
Conditions
Interventions
Group 2:Rocuronium-Sugammadex
Group 1:Cisatracurium - neostigmine
Sponsors
Department of Anesthesiology, Shanghai Chest Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-65 years old; 2. Patients undergoing VATS assisted lung surgery under general anesthesia (single lobectomy) were transferred to PACU immediately after surgery; 3. Patients with normal pulmonary function before operation (FEV1 > 70% of the predicted value, diffusion greater than 70% of the predicted value); 4. Patients with operation time >=1 hour; 5. Subjects of informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with previous mental illness or patients taking psychotropic drugs due to epilepsy; 2. Patients with neuromuscular diseases (myasthenia gravis, progressive muscular dystrophy, periodic paralysis, congenital myopathy, hemiplegia, nervous system diseases, etc.); 3. Patients with mediastinal tumor; 4. With Severe cardio-cerebrovascular, liver, kidney and metabolic diseases; 5. Patients with poor pulmonary function, hypoxemia PaO2 50mmhg; 6. Patients with skin temperature less than 32 degrees C.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FEV1; | — |
Countries
China
Contacts
Public ContactQimeng Yu
Shanghai Chest Hospital
Outcome results
None listed